322 related articles for article (PubMed ID: 25740390)
1. Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy.
Minatsuki S; Miura I; Yao A; Abe H; Muraoka H; Tanaka M; Imamura T; Inaba T; Maki H; Hatano M; Kinugawa K; Yao T; Fukayama M; Nagai R; Komuro I
Int Heart J; 2015; 56(2):245-8. PubMed ID: 25740390
[TBL] [Abstract][Full Text] [Related]
2. Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer.
Kubota K; Shinozaki T; Imai Y; Kario K
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28882938
[TBL] [Abstract][Full Text] [Related]
3. Imatinib Dramatically Improved Pulmonary Hypertension Caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) Associated with Metastatic Breast Cancer.
Yoshikawa S; Hara T; Suzuki M; Fujioka M; Taniguchi Y; Hirata KI
Int Heart J; 2020 May; 61(3):624-628. PubMed ID: 32350209
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib.
Ogawa A; Yamadori I; Matsubara O; Matsubara H
Intern Med; 2013; 52(17):1927-30. PubMed ID: 23994985
[TBL] [Abstract][Full Text] [Related]
5. Imatinib alleviated pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in a patient with metastatic breast cancer.
Fukada I; Araki K; Minatsuki S; Fujino T; Hatano M; Numakura S; Abe H; Ushiku T; Iwase T; Ito Y
Clin Breast Cancer; 2015 Apr; 15(2):e167-70. PubMed ID: 25468406
[No Abstract] [Full Text] [Related]
6. Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma.
Takahashi F; Kumasaka T; Nagaoka T; Wakiya M; Fujii H; Shimizu K; Uchida K; Morio Y; Seyama K; Hino O; Takahashi K; Fukuchi Y
Pathol Int; 2009 Oct; 59(10):752-6. PubMed ID: 19788622
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary tumor thrombotic microangiopathy in patients with gastric carcinoma: an analysis of 6 autopsy cases and review of the literature.
Chinen K; Tokuda Y; Fujiwara M; Fujioka Y
Pathol Res Pract; 2010 Oct; 206(10):682-9. PubMed ID: 20554399
[TBL] [Abstract][Full Text] [Related]
8. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.
Sumida T; Kitadai Y; Shinagawa K; Tanaka M; Kodama M; Ohnishi M; Ohara E; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2011 May; 128(9):2050-62. PubMed ID: 21387285
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
Perros F; Montani D; Dorfmüller P; Durand-Gasselin I; Tcherakian C; Le Pavec J; Mazmanian M; Fadel E; Mussot S; Mercier O; Hervé P; Emilie D; Eddahibi S; Simonneau G; Souza R; Humbert M
Am J Respir Crit Care Med; 2008 Jul; 178(1):81-8. PubMed ID: 18420966
[TBL] [Abstract][Full Text] [Related]
11. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy.
Higo K; Kubota K; Takeda A; Higashi M; Ohishi M
Intern Med; 2014; 53(22):2595-9. PubMed ID: 25400181
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.
Chhina MK; Nargues W; Grant GM; Nathan SD
Future Cardiol; 2010 Jan; 6(1):19-35. PubMed ID: 20014985
[TBL] [Abstract][Full Text] [Related]
13. Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.
Akagi S; Nakamura K; Miura D; Saito Y; Matsubara H; Ogawa A; Matoba T; Egashira K; Ito H
Int Heart J; 2015 May; 56(3):354-9. PubMed ID: 25902888
[TBL] [Abstract][Full Text] [Related]
14. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.
Rosenberg A; Mathew P
Expert Opin Investig Drugs; 2013 Jun; 22(6):787-94. PubMed ID: 23540855
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor inhibition--a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?
Frenckner B; Broomé M; Lindström M; Radell P
J Pediatr Surg; 2008 Oct; 43(10):1928-31. PubMed ID: 18926235
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Tumor Thrombotic Microangiopathy due to Advanced Gastric Cancer with Virchow's Node Metastasis.
Sato T; Mori M; Aoki J; Tanabe K
Int Heart J; 2018 Mar; 59(2):443-447. PubMed ID: 29503403
[TBL] [Abstract][Full Text] [Related]
17. Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.
Jasińska-Stroschein M; Owczarek J; Plichta P; Orszulak-Michalak D
Pharmacology; 2014; 93(3-4):145-50. PubMed ID: 24662671
[TBL] [Abstract][Full Text] [Related]
18. The role of imatinib in the treatment of pulmonary hypertension.
Mucke H
Drugs Today (Barc); 2013 Mar; 49(3):203-11. PubMed ID: 23527324
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma.
Sugiura H; Fujiwara Y; Ando M; Kawai A; Ogose A; Ozaki T; Yokoyama R; Hiruma T; Ishii T; Morioka H; Mugishima H
J Orthop Sci; 2010 Sep; 15(5):654-60. PubMed ID: 20953927
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature.
Ho AL; Szulakowski P; Mohamid WH
BMC Cancer; 2015 Jun; 15():450. PubMed ID: 26036321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
